Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction

Open access

Abstract

Cancer cachexia is a complex multi-organ syndrome characterized by body weight loss, weakness, muscle atrophy and fat depletion. With a prevalence of 1 million people in Europe and only limited therapeutic options, there is a high medical need for new approaches to treat cachexia. Our latest results highlighted microbial dysbiosis, characterized by a bloom in Enterobacteriaceae and altered gut barrier function in preclinical models of cancer cachexia. They also demonstrated the potential of targeting the gut microbial dysbiosis in this pathology. However, the exact mechanisms underlying the gut microbiota-host crosstalk in cancer cachexia remain elusive. In this set of studies, we identified Klebsiella oxytoca as one of the main Enterobacteriaceae species increased in cancer cachexia and we demonstrated that this bacteria acts as a gut pathobiont by altering gut barrier function in cachectic mice. Moreover, we propose a conceptual framework for the lower colonization resistance to K . oxytoca in cancer cachexia that involves altered host gut epithelial metabolism and host-derived nitrate boosting the growth of the gut pathobiont. This set of studies constitutes a strong progression in the field of gut microbiota in cancer cachexia, by dissecting the mechanism of emergence of one bacterium, K . oxytoca , and establishing its role as a gut pathobiont in this severe disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-30569-5

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Klebsiella oxytoca is increased in tumor-bearing mice with cachexia independently of anorexia. (A–C) Cecal K. oxytoca levels in three independent cohorts of sham-injected mice (CT) and C26-injected mice (C26), n = 7–8 for each group of mice. (D) Cecal K. oxytoca levels in sham-injected mice (CT), C26-injected mice (C26), healthy mice pair-fed to sham-injected mice (PFtoCT) and healthy mice pair-fed to C26-injected mice (PFtoC26), n = 7–8. Data are presented as whiskers plots with minimal and maximal values. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 1 Klebsiella oxytoca is increased in tumor-bearing mice with cachexia independently of anorexia. (A–C) Cecal K. oxytoca levels in three independent cohorts of sham-injected mice (CT) and C26-injected mice (C26), n = 7–8 for each group of mice. (D) Cecal K. oxytoca levels in sham-injected mice (CT), C26-injected mice (C26), healthy mice pair-fed to sham-injected mice (PFtoCT) and healthy mice pair-fed to C26-injected mice (PFtoC26), n = 7–8. Data are presented as whiskers plots with minimal and maximal values. *p < 0.05; **p < 0.01; ***p < 0.001.CC BY · PubMed Central
Figure 2 Expansion in Proteobacteria at the expense of the Ruminococcaceae and Lachnospiraceae families in cachectic mice. (A) Stacked plots displaying the mean of the relative abundance of each phylum. (B) Stacked plots displaying the mean of the relative abundance of each family within the Clostridiales order. (C) Heat map representation of the Spearman rank-order correlation coefficient rho between all bacterial families detected by Illumina sequencing of the 16S rRNA gene. *q < 0.05. Mean, SEM, p- and q-values for all phyla and families are presented in Table S1, n = 5 for sham-injected mice (CT) and n = 8 for C26-injected mice (C26).
Figure 2 Expansion in Proteobacteria at the expense of the Ruminococcaceae and Lachnospiraceae families in cachectic mice. (A) Stacked plots displaying the mean of the relative abundance of each phylum. (B) Stacked plots displaying the mean of the relative abundance of each family within the Clostridiales order. (C) Heat map representation of the Spearman rank-order correlation coefficient rho between all bacterial families detected by Illumina sequencing of the 16S rRNA gene. *q < 0.05. Mean, SEM, p- and q-values for all phyla and families are presented in Table S1, n = 5 for sham-injected mice (CT) and n = 8 for C26-injected mice (C26).CC BY · PubMed Central
Figure 3 Mechanisms of emergence of Klebsiella oxytoca in cachectic mice. (A–D) Cecal Pparg, Nos2, Cpt1a, and Hk2 expression in sham-injected mice (CT) and C26-injected mice (C26), n = 7–8. (E) Pearson correlation between cecal K. oxytoca levels and cecal Nos2 expression, n = 14. (F) Optical density (OD) over time of a simplified medium enriched or not with nitrate and inoculated with K. oxytoca. This graph is the result of three independent experiments performed in duplicate. (G) Cecal Foxp3 expression in sham-injected mice (CT) and C26-injected mice (C26), n = 7–8. Data are presented as mean ± SEM. #p < 0.1; *p < 0.05; ***p < 0.001.
Figure 3 Mechanisms of emergence of Klebsiella oxytoca in cachectic mice. (A–D) Cecal Pparg, Nos2, Cpt1a, and Hk2 expression in sham-injected mice (CT) and C26-injected mice (C26), n = 7–8. (E) Pearson correlation between cecal K. oxytoca levels and cecal Nos2 expression, n = 14. (F) Optical density (OD) over time of a simplified medium enriched or not with nitrate and inoculated with K. oxytoca. This graph is the result of three independent experiments performed in duplicate. (G) Cecal Foxp3 expression in sham-injected mice (CT) and C26-injected mice (C26), n = 7–8. Data are presented as mean ± SEM. #p < 0.1; *p < 0.05; ***p < 0.001.CC BY · PubMed Central
Figure 4 Klebsiella oxytoca does not affect gut barrier function in healthy mice. (A) Fecal K. oxytoca levels in healthy mice receiving the vehicle (CT) or K. oxytoca in their drinking bottle (Kox). (B) In black, number of mice for which coliform bacteria were detected in their mesenteric lymph nodes (MLN). (C-F) Ileal mRNA expression levels of key markers involved in gut permeability, epithelium renewal, mucosal immunity and antimicrobial peptide production. Data are presented as whiskers plots with minimal and maximal values (A) or mean ± SEM (C–F). N = 7–8. *p < 0.05; ***p < 0.001.
Figure 4 Klebsiella oxytoca does not affect gut barrier function in healthy mice. (A) Fecal K. oxytoca levels in healthy mice receiving the vehicle (CT) or K. oxytoca in their drinking bottle (Kox). (B) In black, number of mice for which coliform bacteria were detected in their mesenteric lymph nodes (MLN). (C-F) Ileal mRNA expression levels of key markers involved in gut permeability, epithelium renewal, mucosal immunity and antimicrobial peptide production. Data are presented as whiskers plots with minimal and maximal values (A) or mean ± SEM (C–F). N = 7–8. *p < 0.05; ***p < 0.001.CC BY · PubMed Central
Figure 5 Klebsiella oxytoca hampers gut barrier function in cachectic mice. (A) Fecal K. oxytoca levels in healthy mice receiving the vehicle (CT), in C26-transplanted mice receiving the vehicle (C26) and in C26-transplanted mice receiving K. oxytoca in their drinking bottle (C26-Kox). (B) In black, number of mice for which coliform bacteria were detected in their mesenteric lymph nodes (MLN). (C) Fecal K. oxytoca levels in mice displaying coliform bacteria in their MLN and in mice free of coliform bacteria in their MLN, within the C26-Kox group. (D–G) Ileal mRNA expression levels of key markers involved in gut permeability, epithelium renewal, mucosal immunity and antimicrobial peptide production. Data are presented as whiskers plots with minimal and maximal values (A) or mean ± SEM (C–G). The dotted line indicates the expression level in sham-injected mice. N = 7–8. #p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 5 Klebsiella oxytoca hampers gut barrier function in cachectic mice. (A) Fecal K. oxytoca levels in healthy mice receiving the vehicle (CT), in C26-transplanted mice receiving the vehicle (C26) and in C26-transplanted mice receiving K. oxytoca in their drinking bottle (C26-Kox). (B) In black, number of mice for which coliform bacteria were detected in their mesenteric lymph nodes (MLN). (C) Fecal K. oxytoca levels in mice displaying coliform bacteria in their MLN and in mice free of coliform bacteria in their MLN, within the C26-Kox group. (D–G) Ileal mRNA expression levels of key markers involved in gut permeability, epithelium renewal, mucosal immunity and antimicrobial peptide production. Data are presented as whiskers plots with minimal and maximal values (A) or mean ± SEM (C–G). The dotted line indicates the expression level in sham-injected mice. N = 7–8. #p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001.CC BY · PubMed Central
Figure 6 Based on our findings and previous literature in the field, we propose a conceptual framework for the emergence of K. oxytoxa in cachectic mice. In such framework, reduction in three butyrate-producing microbial families (Ruminococcaceae, Lachnospiraceae and Porphyromonadaceae) fosters a reduced PPAR-γ signaling, which leads to an increased iNOS expression. This reduced PPAR-γ signaling promotes a glycolytic switch (higher glycolysis and reduced β-oxidation), that together with a reduced Tregs abundance, allows the emergence of K. oxytoca. Host-derived nitrate production also contributes to the growth of the bacterium.
Figure 6 Based on our findings and previous literature in the field, we propose a conceptual framework for the emergence of K. oxytoxa in cachectic mice. In such framework, reduction in three butyrate-producing microbial families (Ruminococcaceae, Lachnospiraceae and Porphyromonadaceae) fosters a reduced PPAR-γ signaling, which leads to an increased iNOS expression. This reduced PPAR-γ signaling promotes a glycolytic switch (higher glycolysis and reduced β-oxidation), that together with a reduced Tregs abundance, allows the emergence of K. oxytoca. Host-derived nitrate production also contributes to the growth of the bacterium.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 127

Metadata

Authors
Pötgens, S. A., Brossel, H., Sboarina, M., Catry, E., Cani, P. D., Neyrinck, A. M., Delzenne, N. M., & Bindels, L. B.
Affiliations
  • UCLouvain (BE)
  • Walloon Excellence in Lifesciences and Biotechnology (BE)
Corresponding author
Bindels, Laure B.
Venue
Scientific Reports
Published
2018-08-17
Volume
8
Issue
1
Pages
12321-12321
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2886815222
Cited by
114
References
50
Citations by year
2026: 17 · 2025: 13 · 2024: 12 · 2023: 12 · 2022: 16 · 2021: 20 · 2020: 13 · 2019: 11
FWCI
3.91
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
  • DIAL (Catholic University of Leuven) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • ORBi (University of Liège) (submittedVersion, other-oa)
Funders
  • University of Minnesota
  • European Commission (613979)
  • Fonds De La Recherche Scientifique - FNRS (WELBIO-CR-2017C-02)
  • Vlaamse regering
  • Walloon excellence in life sciences and biotechnology (WELBIO-CR-2017C-02)
  • FP7 Ideas: European Research Council (336452)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
Klebsiella oxytoca, cancer cachexia, gut dysbiosis, Enterobacteriaceae, intestinal barrier, intestinal dysfunction, colonization resistance, nitrate, host-microbe crosstalk
MeSH terms
Gastrointestinal Microbiome, Animals, Cachexia, Intestinal Diseases, Male, Neoplasms, Klebsiella oxytoca, Gastrointestinal Tract, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. https://app.cochat.ai/papers/10.1038/s41598-018-30569-5
The paper
Pötgens, S. A., Brossel, H., Sboarina, M., Catry, E., Cani, P. D., Neyrinck, A. M., Delzenne, N. M., & Bindels, L. B. (2018). Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Scientific Reports. https://doi.org/10.1038/s41598-018-30569-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.